Tidl Sport Plant Powered

Description

The product is available in two sizes: 30 ml (NDC 79740-006-01) and 90 ml (NDC 79740-006-02). The package label features images corresponding to both sizes, providing a visual reference for identification.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints, including those related to arthritis, simple backache, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 10 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is performed with clean hands and that the affected area is free from any other topical products prior to administration.

For children under 10 years of age, it is advised to consult a physician before use to determine the appropriate course of action and dosage.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be used while smoking or in proximity to heat or flame due to the risk of fire or explosion. Contact with the eyes or mucous membranes must be avoided to prevent irritation or injury. Application to wounds or damaged skin is contraindicated, as it may exacerbate the condition. Additionally, the product should not be applied to irritated skin, as this may lead to further irritation or adverse reactions.

Bandaging the area after application is not recommended, as it may alter the product's effectiveness or increase the risk of skin reactions. The use of heating pads or devices in conjunction with this product is contraindicated due to the potential for increased skin irritation or burns.

Patients should discontinue use and consult a healthcare professional if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then reoccur within a few days.

Warnings and Precautions

For external use only. This product is flammable; therefore, it should not be used while smoking or in proximity to heat or open flames.

When utilizing this product, it is imperative to avoid contact with the eyes and mucous membranes. Application to wounds, damaged skin, or irritated skin is contraindicated. Additionally, the product should not be bandaged after application. Users are advised to wash their hands thoroughly with cool water following use. The application of this product in conjunction with heating pads or devices is not recommended.

Patients should discontinue use and consult a healthcare professional if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then reoccur within a few days.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only and is flammable; therefore, it should not be used while smoking or near heat or flame.

When applying the product, patients must avoid contact with the eyes or mucous membranes and should not apply it to wounds, damaged skin, or irritated skin. Additionally, it is advised not to bandage the area after application and to wash hands thoroughly with cool water following use. The product should not be used in conjunction with heating pads or devices.

Patients are instructed to discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then reoccur within a few days. It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is recommended.

These precautions are essential to ensure the safe use of the product and to minimize the risk of adverse reactions.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Tidl Sport Plant Powered (tidl sport plant powered spray). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 10 years of age should consult a physician prior to use. For children aged 10 years and older, the recommended dosage is to apply the medication to the affected area no more than 3 to 4 times daily.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

There is currently no information available regarding the use of TIDL Sport Plant Powered Spray during pregnancy. This includes any safety concerns, dosage modifications, or special precautions that may be necessary for pregnant patients. Healthcare professionals are advised to exercise caution and consider the lack of data when prescribing this product to women who are pregnant or may become pregnant. It is recommended that the potential risks and benefits be carefully weighed in these situations.

Lactation

There are no specific statements regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to this population, as the absence of detailed guidance necessitates careful clinical judgment regarding the use of the medication in individuals with reduced kidney function. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure safety and therapeutic effectiveness.

Overdosage

In the event of an overdosage, it is imperative to keep the medication out of reach of children. Accidental ingestion can occur, and in such cases, immediate medical assistance should be sought. Healthcare professionals are advised to contact a Poison Control Center without delay to ensure appropriate management and intervention.

Prompt action is crucial in mitigating potential adverse effects associated with overdosage. The symptoms may vary depending on the specific medication involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

In summary, vigilance in preventing access to the medication by children and swift action in the case of accidental ingestion are essential components of effective overdosage management.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the extracted data.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is accidentally ingested, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product while smoking or near heat or flame. When using this product, it is essential to avoid contact with the eyes or mucous membranes. Patients should be cautioned against applying the product to wounds, damaged skin, or irritated skin, and they should not bandage the area after application. It is also important for patients to wash their hands with cool water after use and to avoid using the product in conjunction with a heating pad or any heating device.

Healthcare providers should instruct patients to stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then reoccur within a few days.

Storage and Handling

The product is available in various package configurations, identified by their respective National Drug Code (NDC) numbers. Specific NDC numbers are not provided in the available information.

Currently, there are no specific storage or handling instructions outlined for this product. It is advisable to follow standard pharmaceutical storage practices to ensure product integrity.

Additional Clinical Information

The medication is administered topically, with application to the affected area recommended no more than 3 to 4 times daily. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Tidl Sport Plant Powered, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)